MEKANISME AKSI ANTIJAMUR MINYAK MASOYI TERHADAP MEMBRAN SEL Candida albicans

FRENITA BURHAN
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

DAFTAR PUSTAKA

Al-Attas, S.A., Amro, S.O., 2010. Candidal colonization, strain diversity, and
antifungal susceptibility among adult diabetic patients. Medical Saudi. 30,
101–108.
Alexander, M., Bloom, B.R., Hopwood, D.A., Hull, R., Iglewski, B.H., Laskin,
A.I., et al., 2000. Encyclopedia of Microbiology, Four-Volume. Second
Edition. Academic Press, New York.1132-1145
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., Pitula, A., 2004.
Development and characterization of an in vivo central venous catheter
Candida albicans biofilm model. Infection Immunology. 72, 6023–6031.
Ashley, E.S.D., Lewis, R., Lewis, J.S., Martin, C., Andes, D., 2006. Pharmacology
of Systemic Antifungal Agents. Clinical Infection Disease. 43
Barros, M.E.S.B., Freitas, J.C.R., Oliveira, J.M., Da Cruz, C.H.B., da Silva, P.B.N.,
de Araújo, L.C.C., et al., 2014. Synthesis and evaluation of (−)-
massoialactone and analogues as potential anticancer and anti-inflammatory
agents. European Journal of Medicinal Chemistry, 76, 291–300.
Bafadal, M., Hertiani, T., Yuswanto, A., 2016. 'Efek Minyak Masoyi (Massoia
aromatic Becc.) Terhadap Kultur Multispesies Biofilm'. Tesis, MSc,
Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta Indonesia.

Berman, J., Sudbery, P.E., 2002. Candida albicans: a molecular revolution built on
lessons from budding yeast. National Genetica. Review. 3, 918–930.
Biswas, S.K., Chaffin, W.L., 2005. Anaerobic growth of Candida albicans does not
support biofilm formation under similar conditions used for aerobic biofilm.
Current Microbiology. 51, 100–104.
Brooks, G.. F., Carroll, K.C., Butel, J.S., Morse, S.A., 2007. Medical Microbiology,
24 th Edition. Editor: Jawetz, Melnick & Adelberg’s, McGraw-Hill
Medical. 654-720.
Brown, A.J., Gow, N.A., 1999. Regulatory networks controlling Candida albicans
morphogenesis. Trends Microbiology. 7, 333–338.
Casadevall, A., Pirofski, L.A., 1999. Host-pathogen interactions: redefining the
basic concepts of virulence and pathogenicity. Infection Immunology. 67,
3703–3713.

Chaturvedi, D., Mishra, B.B., Tiwari, V.K., 2011. ‘Opportunity, challenge and
scope of natural products in medicinal chemistry’ Thesis, Departement of
chemistry, faculty of Science, Banaras Hindu Unversoty Vanarasi-221005,
India. 102-105.

1
 MEKANISME AKSI ANTIJAMUR MINYAK MASOYI TERHADAP MEMBRAN SEL Candida albicans
FRENITA BURHAN
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

Cleary, J.D., Chapman, S.W., Nolan, R.L., 1992. Pharmacologic modulation of

interleukin-1 expression by amphotericin B-stimulated human mononuclear
cells. Antimicrobiology Agents Chemother. 36, 977–981.
Dan , M., 2009. Efektifitas minyak masoyi (Massoia aromatica) terhadap helopeltis
antonii sign pada jambu mete dan Chrysocoris javanus pada jarak pagar.
Peneliti Tanaman. 140.
Ghannoum, M.A., Rice, L.B., 1999. Antifungal agents: mode of action,
mechanisms of resistance, and correlation of these mechanisms with
bacterial resistance. Clinical Microbiology. Review. 12, 501–517.
Grubb, S.E.W., Murdoch, C., Sudbery, P.E., Saville, S.P., Lopez-Ribot, J.L.,
Thornhill, M.H., 2008. Candida albicans-endothelial cell interactions: a key
step in the pathogenesis of systemic candidiasis. Infection Immunology. 76,
4370– 4377.
Ha, K.C., White, T.C., 1999. Effects of Azole Antifungal drugs on the transition
from yeast Cells to hyphae in susceptible and resistant isolates of the
pathogenic yeast Candida albicans. Antimicrobiology Agents Chemother.
43, 763– 768.
Haris, R., 1993. Tanaman Minyak Atsiri. Cetakan IV. Penerbit Penebar Swadaya,
Jakarta.
Hertiani, T., Pratiwi, S. U. T., Yuswanto, A., Permanasari, P., 2016. Potency of
Massoia Bark in combating immunosuppressed - related infection.
Pharmacognosy Magazine. 12.
Heyne, K., 1950, Tumbuhan berguna Indonesia, diterjemahakan dari Bahasa
Inggris oleh Badan Penelitian dan Pengembangan Kehutanan,. Yayasan
Sarana Wana Jaya : Diedarkan oleh Koperasi Karyawan, Departemen
Kehutanan, Jakarta.
Hidayat, U., Sudarmin, S., Siadi, K., 2012. Uji aktivitas senyawa hasil oksidasi
Kariofilena dengan KMnO4 terhadap Candida albicans. Indonesian
Journal Chemical Science. 1. 3-4.
Iskandar, M.I. dan Ismanto, A., 1999. Tinjauan beberapa sifat Dan Manfaat
Tumbuhan Masoyi (Massoia Aromaticum Becc.). Warta Tumbuhan Obat
Indonesia. 5.
Jacob M. H., Ellen, C.J., Amber, D.E., 2001. Quorum sensing in the dimorphic
fungus Candida albicans is mediated by farnesol. Aplied Enviromental
Microbilogy .2982-2992.
Jong, A.Y., Stins, M.F., Huang, S.H., Chen, S.H., Kim, K.S., 2001. Traversal of
Candida albicans across human blood-brain barrier in vitro. Infection
Immunology. 69, 4536–4544.

2
 MEKANISME AKSI ANTIJAMUR MINYAK MASOYI TERHADAP MEMBRAN SEL Candida albicans
FRENITA BURHAN
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

Khan, M.S.A., Ahmad, I., Aqil, F., Owais, M., Shahid, M., Musarrat, J., 2010.
Virulence and pathogenicity of fungal pathogens with special reference to
Candida albicans, combating fungal infections. Springer Berlin
Heidelberg, Berlin, Heidelberg. 21–45.
Khanna, N., 2007. Antimicrobial Agents: Antifungal & Antiviral Drugs. 2564-
2568
Khishimoto, N., Sugihara, S., Mochida, K., 2005. In vitro antifungal and antiviral
activities of γ- and δ-lactone analog utilized as food flavoring. Biocontrol
Science. 3-5
Larabi, M., Legrand, P., Appel, M., Gil, S., Lepoivre, M., Devissaguet, J.-P.,
Puisieux, F., et al., 2001. Reduction of NO synthase expression and tumor
necrosis factor alpha production in macrophages by Amphotericin B lipid
Carriers. Antimicrobiology Agents Chemother. 45, 553–562.
Lee, W., Lee, D.G., 2014. An antifungal mechanism of curcumin lies in membrane-
targeted action within Candida albicans. IUBMB Life. 1-7
Lodder, J., Kreger, V.R.N.J.W., 1967. Lodder, J. 1970. The Yeasts: a taxonomic
study. North-Holland Public. Cambridge, United Kingdom. 3605-3625.
Madigan, M.T., Martinko, J., Parker, J., 2002. Brock Biology of Microorganisms,
10 edition. Prentice Hall, Upper Saddle River. 1454.
Martin, S.W., Douglas, L.M., Konopka, J.B., 2005. Cell cycle dynamics and
quorum sensing in Candida albicans chlamydospores are distinct from
budding and hyphal growth. Eukaryot Cell. 4, 1191–1202.
Mayer, F.L., Wilson, D., Hube, B., 2013. Candida albicans pathogenicity
mechanisms. Virulence. 4, 119–128.
McGaw, L.J., Lall, N., Meyer, J.J.M., Eloff, J.N., 2008. The potential of South
African plants against Mycobacterium infections. Journal
Ethnopharmacol., (Ethnobotany in South Africa) 119, 482–500.
Muhlisah, F., 2007. Tanaman Obat Keluarga (Revisi). Niaga Swadaya, Jakarta,
Indonesia. 8-10.
Naglik, J., Albrecht, A., Bader, O., Hube, B., 2004. Candida albicans proteinases
and host pathogen interactions. Cell Microbiology. 6, 915–926.
Nawangningrum, D., 2004. Kajian terhadap naskah kuna nusantara koleksi Fakultas
Ilmu Pengetahuan Budaya Universitas Indonesia: Penyakit dan pengobatan
ramuan tradisional. Seri Sosial Humaniora (Social Humanities Series); Vol
8, No: 2.
Pauli, A., 2006. Anticandidal low molecular compounds from higher plants with
special reference to compounds from essential oils. Medical Research
Review. 26, 223– 268.

3
 MEKANISME AKSI ANTIJAMUR MINYAK MASOYI TERHADAP MEMBRAN SEL Candida albicans
FRENITA BURHAN
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

Pratiwi, S.U.T., Lagendijk, E.L., Weert, S. de, Hertiani, T., Idroes, R., Hondel,
C.A.V.D., 2015. Effect of Cinnamomum burmannii Nees ex Bl. and
Massoia aromatica Becc. essential oils on planktonic growth and biofilm
formation of Pseudomonas aeruginosa and Staphylococcus aureus In Vitro.
International Journal of Applied Research in Natural Products.. 8, 1–13.
Rali, T., Wossa, S.W., Leach, D.N., 2007. Comparative chemical analysis of the
essential oil constituents in the bark, heartwood and fruits of Cryptocarya
massoy (Oken) Kosterm. (Lauraceae) from Papua New Guinea. Molecul.
Basel Switz. 12, 149–154.
Ramage, G., Saville, S.P., Thomas, D.P., López-Ribot, J.L., 2005. Candida
biofilms: an update. Eukaryot. Cell 4, 633–638.
Samaranayake, L.P., Fidel, P.L., Naglik, J.R., Sweet, S.P., Teanpaisan, R., Coogan,
M.M., Blignaut, E., Wanzala, P., 2002. Fungal infections associated with
HIV infection. Oral Disease. Suppl 2, 151–160.
Sangetha, S., Zuraini, Z., Suryani, S., Sasidharan, S., 2009. In situ TEM and SEM
studies on the antimicrobial activity and prevention of Candida albicans
biofilm by Cassia spectabilis extract. Micron (Oxford England. 1993) 40,
439–443.
Schell, R.E., 1993. Proton permeability of renal membranes: influence of
amphotericin B. Nephron. 63, 481.
Sheppard, D., Lampiris, H.W., 2007. Antifungal Agents Basic & Clinical
Pharmacology, 12e. Access Pharmacy. McGraw-Hill Medical. 3256.
Silva, M.G.V., Vieira, I.G.P., Mendes, F.N.P., Albuquerque, I.L., dos Santos, R.N.,
Silva, F.O., et al., 2008. Variation of ursolic acid content in eight Ocimum
species from Northeastern Brazil. Molecules Basel Switz. 13, 2482–2487.
Subroto, H.M.& M.A., 2006. Gempur Penyakit dengan Minyak Herbal Papua, 6.
Agro Media. 25-37.
Sudbery, P., Gow, N., Berman, J., 2004. The distinct morphogenic states of
Candida albicans. Trends Microbiology. 12, 317–324.
Soegihardjo, C.J., 1990, Masoyi (Massoia aromatic Becc.) dan Daun jintan
(Coleusamboinicus Lour.) dengan teknik kultur jaringan, Laporan
Penelitian,
Lembaga Penelitian UGM, Yogyakarta.
Sukandar, E.Y., Andrajati, R., Sigit, J., Setiadi, A.., Kusnandar, 2008. ISO
Farmakoterapi. PT. ISFI Penerbitan, Jakarta, Indonesia. 250-255.
Tashiro, M., Kimura, S., Tateda, K., Saga, T., Ohno, A., Ishii, Y., et al., 2012.
Pravastatin inhibits farnesol production in Candida albicans and improves

4
 MEKANISME AKSI ANTIJAMUR MINYAK MASOYI TERHADAP MEMBRAN SEL Candida albicans
FRENITA BURHAN
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

survival in a mouse model of systemic candidiasis. Medical Mycology. 50,

353–360.
Tietz, H.-J., 2010. Treatment of chronic vulvovaginal candidiasis with
posaconazole and ciclopiroxolamine. Health. 2, 513–518.
Tisserand, R., Young, R., 2014. Essential Oil Safety. A Guide for Health Care
Professionals - Second Edition 16478-16479.
Tisserand, R., Young, R., 2013. Essential Oil Safety: A Guide for Health Care
Professionals. Elsevier Health Sciences. 16175-16187.
Tiwari, V.K., Mishra, B.B., 2011. Opportunity, challenge and scope of natural
products in medicinal chemistry. Research Signpost. Trivandrum, India.
107, 382-425.
Tortora, G.J., Funke, B.R., Case, C.L., 2004. Microbiology An Introduction 8th
Edition, Benjamin-Cummings Publisher. 567-722.
Warenda, A.J., Kauffman, S., Sherrill, T.P., Becker, J.M., Konopka, J.B., 2003.
Candida albicans septin mutants are defective for invasive growth and
virulence. Infection Immunology. 71, 4045–4051.
Wilson, L.S., Reyes, C.M., Stolpman, M., Speckman, J., Allen, K., Beney, J., 2002.
The direct cost and incidence of systemic fungal infections. Value Health
Journal International Social Pharmacoeconomics Outcomes Research. 5,
26–34.
Wingard, J.R., Leather, H., 2004. A new era of antifungal therapy. Biololgy Blood
Marrow Transplant. 10, 73–90.